The IPO List
HomeListingsBlogsAboutJoin WhatsApp CommunityWhatsApp(Opens in a new tab)

The IPO List

Your trusted platform for IPO tracking and investment insights.

Quick Links

IPOsIPO ArchiveBlogsGMP AccuracyMethodologyAboutContact

Legal

Privacy PolicyTerms of ServiceDisclaimer

© 2026 The IPO List. All rights reserved.

  1. Home/
  2. IPO Calendar/
  3. Symbiotec Pharmalab IPO
Symbiotec Pharmalab
MainboardListed

Symbiotec Pharmalab IPO

Bidding 24-27 Aug 2026, price band ₹938–988, lot 15 shares.

0%
listing gain
OverviewGMPSubscriptionAllotment

Grey Market Premium Trend

GMP last updated: 1 Sept 2026, 9:36 AM IST

₹185
Final GMP
0%
Actual Listing Gain
18.7%
GMP-Implied Gain
₹938 - ₹988
Price Band

GMP History

DateGMP (₹)Est. Listing Price (₹)Est. Listing Gain
31 Aug₹185₹1,17318.72%
30 Aug₹185₹1,17318.72%
29 Aug₹240₹1,22824.29%
28 Aug₹240₹1,22824.29%
27 Aug₹265₹1,25326.82%
26 Aug₹270₹1,25827.33%
25 Aug₹285₹1,27328.85%
24 Aug₹352₹1,34035.63%
23 Aug₹335₹1,32333.91%
22 Aug₹409₹1,39741.40%
21 Aug₹410₹1,39841.50%
20 Aug₹345₹1,33334.92%
19 Aug₹300₹1,28830.36%
18 Aug₹220₹1,20822.27%

IPO timeline

  1. Issue open date
    24 Aug 2026
  2. Issue close date
    26 Aug 2026
  3. UPI mandate deadline
    26 Aug 2026
  4. Allotment finalization
    27 Aug 2026
  5. Refund initiation
    28 Aug 2026
  6. Share credit
    28 Aug 2026
  7. Listing date
    31 Aug 2026
  8. Mandate end date
    10 Sep 2026
  9. Lock-in end date for anchor investors (50%)
    25 Sep 2026
  10. 10
    Lock-in end date for anchor investors (remaining)Next
    24 Nov 2026

Symbiotec Pharmalab IPO Allotment Status

Allotment date:27 Aug 2026
Registrar:MUFG Intime India Private Limited - Link Intime
  1. Open the registrar's allotment page from the link below.
  2. Select Symbiotec Pharmalab from the list of companies.
  3. Enter your PAN, application number or demat account (DP/Client ID).
  4. Submit to see how many shares you were allotted.
Check allotment on MUFG Intime India(Opens in a new tab)BSE application status check(Opens in a new tab)

After allotment

Refund / mandate release:28 Aug 2026
Shares credited to demat:28 Aug 2026
Listing:31 Aug 2026
💸

IPO Subscription Status

CategoryTimesEst. Allotment Chances*
HNIs (Total)77.53🔥1.3%
bHNI87.34🔥1.1%
sHNI57.91🔥1.7%
QIBs181.2🔥-
Retail13.52🔥7.4%
Employees16.19🔥6.2%
Total74.98🔥-

*Rough estimate: 1 ÷ times subscribed. Retail and HNI allotment is by lottery, so actual odds depend on the number of applications.

Last updated: 27 August'26 04:44PM

Quick Stats

Issue Size:1757cr
Lot Size:15 shares
Min Investment:₹14,820
P/E Ratio:55.44

Additional Resources

ProspectusRead(Opens in a new tab)

About the Company

Symbiotec Pharmalab is a pharmaceutical company engaged in developing and manufacturing active pharmaceutical ingredients, contract development and manufacturing solutions, and complex injectables. The company operates an integrated business model supported by research and development, fermentation, and organic chemistry capabilities. Its active pharmaceutical ingredient portfolio primarily focuses on steroidal products, while its contract development and manufacturing business offers development and manufacturing services for pharmaceutical, nutraceutical, and other life science companies. The company also develops complex injectable products, including double-chamber formats, and leverages its in-house active pharmaceutical ingredient capabilities to support these offerings. Revenue is generated through the sale of active pharmaceutical ingredients, contract development and manufacturing services, and complex injectable products. Its business is supported by backward integration in key raw material processing, large-scale fermentation capacity, and multiple manufacturing facilities, enabling it to serve customers across regulated and global markets.

Strengths

  • Operates an integrated business across APIs, CDMO services and complex injectables.
  • Has one of India’s largest industrial-scale fermentation capacities with 700 KL capacity.
  • Backward integration reduces dependence on external sources for key intermediates.
  • Develops differentiated double-chamber injectable products using in-house API capabilities.
  • Long-term manufacturing agreements and strategic partnerships support future business growth.

Risks

  • Almost all revenue comes from API products, making the business dependent on API demand.
  • A large share of revenue comes from a few key customers, and losing them could hurt the business.
  • The company depends on key suppliers for raw materials, and supply disruptions could affect operations.
  • The company faces intense competition in both the API and CDMO businesses.
  • Failure to meet repayment obligations or loan covenants could adversely affect the business and finances.

Symbiotec Pharmalab IPO – Frequently Asked Questions

  • The price band for the Symbiotec Pharmalab IPO is set at ₹938 to ₹988 per share.
  • The Symbiotec Pharmalab IPO opens on August 24, 2026 and closes on August 27, 2026.
  • The tentative listing date for the Symbiotec Pharmalab IPO is August 31, 2026.
  • The last recorded Grey Market Premium (GMP) for the Symbiotec Pharmalab IPO before listing was ₹185 (18.72%). GMP is unofficial and is not a guarantee of the listing price.
  • The Symbiotec Pharmalab IPO listed on August 31, 2026 with a listing gain of 0% over its issue price.
  • The Symbiotec Pharmalab IPO allotment date is August 27, 2026. Once it is finalised, check your status with your PAN or application number on the website of the registrar, MUFG Intime India Private Limited - Link Intime. Issues listed on BSE can also be checked on the BSE application status page.
  • You can apply for the Symbiotec Pharmalab IPO via your broker or bank using ASBA or UPI. Log in to your trading app (Zerodha, Upstox, Groww, etc.), select IPO section, choose Symbiotec Pharmalab, enter lot quantity and UPI ID, then approve the mandate.
  • The lot size for the Symbiotec Pharmalab IPO is 15 shares. Investors must apply for at least one lot (i.e., 15 shares), which costs ₹14,820 at the upper price band.

Related IPOs

Open and upcoming

  • Friends Union for Energising Lives (FUEL)Bidding 11-20 Nov 2026
    Open
  • Crystal Crop ProtectionBidding 18-20 Nov 2026
    Open
  • Mahanadi CoalfieldsBidding 19-23 Nov 2026
    Upcoming
  • Watrana RentalsBidding 19-23 Nov 2026
    Upcoming

Recent mainboard listings

  • Bombay Coated & Special SteelsListed 5 Nov 2026
    +10.98%
  • M.K.Sons Fine JewelsListed 4 Nov 2026
    +5.56%
  • BLS PolymersListed 3 Nov 2026
    +65.33%
  • SFC Environmental TechnologiesListed 3 Nov 2026
    +7.61%
  • EAAA India AlternativesListed 2 Nov 2026
    +0.63%
  • Jio PlatformsListed 28 Oct 2026
    +21.36%

All IPOs that opened in August 2026